Najam Sharif

Company: Nanoscope Therapeutics Inc

Job title: Vice President, Global Research & Development

Seminars:

Harnessing Retinal Imaging Modalities to Evaluate the Efficacy of Optogenetic Therapy 3:00 pm

Utilizing OCT detect optogenetically treated retinal areas Monitoring functional changes in optogenetically sensitized retinal cells in response to light stimulation Employing OCT to assess structural alterationsRead more

day: Conference Day Two